Funding opportunities directory
Browse hundreds of verified grants, scholarships, benefits, fellowships, and loans — filtered by type, location, and deadline. Updated daily.
Browse the canonical directory, then use search and filters to narrow by topic, funding type, location, or deadline. Filtered URLs are treated as browse states; high-intent topics are linked below as curated indexable landing pages.
Halt the Hitchhiker: Invasive Species Challenge (2026–2027)
A federal 3-phase prize challenge led by the U.S. Bureau of Reclamation for watercraft-based solutions that reduce transport of invasive aquatic species through ballast water, with up to $550,000 in phase-based awards.
RFA-DK-26-315: Advancing Research on Digital Health Technology for Type 2 Diabetes (R01)
NIH RFA-DK-26-315 is a clinical-trial R01 opportunity for U.S. institutions to test digital health approaches to improve type 2 diabetes management, with submission cycles in 2026 and 2027 and a strict non-responsiveness rule against tool-building and T1D-only projects.
NIH RFA-DA-25-024: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
NIH NIDA RFA-DA-25-024 supports high-priority research at the intersection of HIV and substance use, including prevention, treatment, cure, and implementation work with R01 funding flexibility and clinical trials optional.
NIH RFA-NS-26-001: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
This NIH opportunity funds research that uses expanded-access data from investigational ALS treatments to support studies in patient populations that cannot enter ongoing clinical trials, with $40,000,000 in FY 2026/27 program funding and a four-award cap for the cycle.
Rapid Response to Emerging and Re-emerging Pest and Disease Events Across Food and Agricultural Systems (A1713): Urgent USDA NIFA Funding
Open competitive NIFA/AFRI funding for urgent, qualifying pest or disease events in food and agricultural systems, with 12–24 month projects and up to $500,000 including indirect costs.
RFA-HG-25-009: Supporting Talented Early Career Researchers in Genomics (R01)
NIH/NHGRI reissues an R01-style NOFO for highly promising Early Stage Investigators (ESIs) building independent genomics programs, with a maximum direct-cost budget of $400,000 per year and up to a five-year project term.
PAR-27-072: Bioengineering Research Grants (R01) for Translational Biomedical Engineering
NIH Bioengineering Research Grants support R01 applications that integrate engineering, quantitative, and physical science approaches to create or adapt technologies and methods that can be translated into biomedical solutions, with recurring deadlines across 2026 and 2027 and open intake.
NSF 24-586: National Quantum Virtual Laboratory - Quantum Testbeds (NQVL)
A U.S. National Science Foundation solicitation supporting Quantum Science and Technology Demonstration projects through QSTD Design and QSTD Implementation phases, with phase-specific funding and strict progress dependencies across Pilot, Design, and Implementation.
Carnegie China Young Ambassadors Internships 2026: How to Apply to a Paid, Rolling-Window Internship in Singapore
Carnegie China’s Young Ambassadors Internships accept rolling applications for paid research and communications tracks, with eligibility tied to student or recent graduate status and eligibility to work in Singapore.
Just Transition Fund North East and Moray Development Grant 2026/27: Up to £300,000 for Planning-Stage Community and Social Enterprise Projects
The 2026/27 Just Transition Fund development grant supports planning-stage projects in North East and Moray with up to £300,000 in resource funding and no fixed closing date while funds remain available.
RFA-HL-26-012: NIH StARR (R38) 2026-2027 Funding for Residency Research Programs
NIH StARR (R38) supports residency programs that give postdoctoral-level clinicians mentored research time and a path toward clinician-investigator careers.
RFA-MH-26-120: BRAIN Initiative Reagent Resources for Brain Cell Type-Specific Access (U24)
NIH’s BRAIN Initiative cooperative agreement funds facilities that produce and distribute brain cell type-specific access and manipulation reagents for neuroscience users.
MRC Equip 2026: Up to £1 Million for Mid-Range Biomedical Research Equipment in UKRI-Eligible Labs
UKRI’s MRC Equip pre-announcement offers up to £1 million FEC for a single piece of capital equipment that supports biomedical research in eligible UK organisations.
NSF 26-017: Empowering and Educating Children to Thrive in a Digital Era
NSF 26-017 is a Dear Colleague Letter inviting U.S. proposals on child digital safety, literacy, and educational well-being through advanced technologies, including AI, with applications routed through linked NSF funding programs.
HORIZON-MISS-2027-03-OCEAN-04: Towards community-driven business models: coastal and freshwaters sustainable tourism
A forthcoming Horizon Europe mission topic to develop community-led coastal and freshwater tourism models that combine local entrepreneurship, conservation outcomes, job creation, and scalable replication across multiple sea basins.
RFA-OD-27-004: INCLUDE Project Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
The NIH INCLUDE Project Transformative Research Awards program supports unusually innovative R01 applications focused on Down syndrome biology and co-occurring conditions with high-risk, high-reward approaches.
Supplements, Facts First: A Digital Adventure for Every Age Challenge
NIH's ODS-led challenge runs in three phases and awards up to $869,000 in prizes to teams that redesign dietary supplement fact-sheet content into multi-modal digital experiences.
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) (PA-25-302)
The NIH R03 parent small research grant supports limited-scope, high-impact projects with direct costs up to $50,000 per year and a project period of up to two years, with multiple NIH ICs reviewing proposals.
RFA-HL-26-003: NHLBI Emerging Investigator Award (EIA) (R35, Clinical Trial Optional)
NIH’s NHLBI Emerging Investigator Award (R35, clinical trial optional) supports established HLBS investigators with at least two NHLBI R01-equivalent grants for up to seven years of flexible, program-level funding, with the next listed due date on 19 February 2027.
Transport Phenomena (PD 26-366Y): NSF 2026 Open Grant Window for Multiscale Fluid and Energy Transport Research
The NSF Transport Phenomena program supports fundamental research in mass, momentum, energy, and species transport with a continuously open full-proposal route through the NSF 24-1 framework.
NIH Oligonucleotide Toxicity (OligoTox) Open Data Challenge
A two-phase NIH prize challenge to generate open in vitro human-system datasets for improving predictive models of oligonucleotide therapeutic toxicity, with Phase 2 submissions open until December 31, 2026.
NIMHD Loan Repayment Program (LRP): 2027 Application Cycle
Application period for the NIH Extramural Loan Repayment Programs through NIMHD opens in Sept 2026 for FY 2027, with annual support up to $50,000 per year for eligible educational debt repayment in exchange for NIH mission-relevant research time.
NIH Quantum Computing Challenge
A two-stage NIH Qu-BIT prize competition for teams developing biomedical use cases in quantum computing, with up to US$1,300,000 in cash awards across stages.
RFA-HL-26-020: Catalyze: Product Definition Medical Device Prototype Optimization (R33)
NHLBI Catalyze RFA-HL-26-020 funds late-stage prototype optimization for medical devices, diagnostics, and research tools for heart, lung, blood, and sleep disorders via R33 awards.
No matching opportunities yet
Try adjusting your filters or clearing them to see more funding programs.